EPO and Hepatic fibrosis: EPO treatment or increasing EPO signaling exhibit protective activity in animal models of liver ischemia-reperfusion injury associated with transplantation including bone marrow-derived mesenchymal stem cell transplantation in a mouse liver fibrosis model [41,42,43,44].